Measuring the incidence of Clostridium difficile-associated diarrhoea in a group of Western Australian hospitals
Helen Van GesselHealth Care Associated Infection Unit, Communicable Diseases Control Directorate, WA Health, Perth, WA 6000, Australia. Email: Helen_vangessel@bigpond.com
Healthcare Infection 13(2) 56-62 https://doi.org/10.1071/HI08010
Published: 18 June 2008
Abstract
Clostridium difficile-associated diarrhoea (CDAD) is a well known healthcare-associated infection, increasing in incidence and severity in much of the developed world. Recommendations for surveillance of CDAD have been published, and CDAD incidence monitoring is increasingly recommended internationally, but unlike many other healthcare-associated infections, there is little comparative data available about CDAD rates in hospitalised patients in Australia. Nine hospitals in Western Australian used standardised definitions and methods to calculate CDAD incidence rates over a 6-month period in 2006, and tested the feasibility of using these protocols in a local context. The overall incidence rate of healthcare-associated CDAD was 1.2 per 10 000 occupied bed days (range 0–3.3 per 10 000 occupied bed days). Calculated rates and hospital rankings varied markedly if separations were used in place of occupied bed days. Each data collection form took a median of 10 min to complete. The short study period and marked variation in laboratory diagnostic practices are limitations to direct comparison of rates between hospitals, but this is a useful and practical method of monitoring CDAD that can be easily incorporated in Australian infection control practice.
Acknowledgements
Ms Allison Peterson RN of the HCAIU made a substantial contribution to the study conception and data acquisition, and deserves particular mention. Thank you to infection control teams and microbiology laboratory staff at the nine HISWA hospitals who so willingly signed up to add this to their already full workload and supported its publication.
[1] Sunenshine R, McDonald LC. Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med 2006; 73 187–97.
| PubMed | [accessed March 2008].
[6]
[7] Muto C, Pokrywka M, Shutt K. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005; 26 273–80.
| Crossref | GoogleScholarGoogle Scholar | [verified May 2008].
[11] McDonald L, Coignard B, Dubberke E, Song X, Horan T, Kutty P, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28 140–5.
| Crossref | GoogleScholarGoogle Scholar | [verified May 2008].
[14] National Clostridium difficile Standards Group Report to the department of health. J Hosp Infect 2004; 56 1–38.
[verified May 2008].
[20] Muto C, Blank M, Marsh J. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university teaching hospital using a comprehensive “bundle” approach. Clin Infect Dis 2007; 45 1266–73.
| Crossref | GoogleScholarGoogle Scholar | [accessed October 2007].
[22]
[23]
[24] Sohn S, Climo M, Diekema D, Fraser V, Herwaldt L, Marino S, et al. Varying rates of Clostridium difficile-associated diarrhoea at prevention epicentre hospitals. Infect Control Hosp Epidemiol 2005; 26 676–9.
| Crossref | GoogleScholarGoogle Scholar | [accessed March 2008].